Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Shares Outstanding (2016 - 2025)

Viridian Therapeutics, Inc.\DE (VRDN) has 6 years of Shares Outstanding data on record, last reported at $28.5 million in Q2 2022.

  • For Q2 2022, Shares Outstanding changed N/A year-over-year to $28.5 million; the TTM value through Jun 2022 reached $28.5 million, changed N/A, while the annual FY2021 figure was $23126.0, 94.2% down from the prior year.
  • Shares Outstanding reached $23126.0 in Q2 2022 per VRDN's latest filing, roughly flat from $23126.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $28.5 million in Q2 2022 and bottomed at $23126.0 in Q3 2021.
  • Average Shares Outstanding over 3 years is $4.6 million, with a median of $376655.0 recorded in 2020.
  • The widest YoY moves for Shares Outstanding: up 93.2% in 2022, down 93.48% in 2022.
  • A 2-year view of Shares Outstanding shows it stood at $260437.0 in 2021, then tumbled by 91.12% to $23126.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $28.5 million in Q2 2022, $212566.0 in Q1 2022, and $23126.0 in Q4 2021.